The
Renaissance
Series
THE FUTURE OF PHARMA
PATIENTS, PREVENTION & MEDICINE
The
Renaissance
Series
THE FUTURE OF PHARMA
PATIENTS, PREVENTION & MEDICINE
LONDON 2024
More Details
What is the Renaissance Series?
LONDON 2024
More Details
What is Renaissance
Goal & Purpose
Pharma companies are exploring prevention strategies with resulting changes in development and investment, as they continue to provide value to stretched healthcare systems.
Diagnostic and genetic advances alongside improved digital technologies, better awareness of future health risk and the increasing role of patient advocacy are also significant drivers .
Prevention is a complex challenge, how do we collaborate to support and contribute to create a healthier society.
The Panel explored
- The shift in focus towards preventative health to help avoid serious disease or delay progression to more complex conditions
- The implications for biopharma and wider stakeholders in healthcare
RENAISSANCE FORUMS
- A unique opportunity to spend a day in closed meeting discussion of the most important challenge for pharma today
- Hear the views of expert speakers from a physician, payer, patient and pharma perspective, all actively involved in addressing this challenge
- Reflect on your own company strategy through informed discussion with the faculty and like-minded senior influencers from leading pharma companies
RENAISSANCE FORUMS
- A unique opportunity to spend a day in closed meeting discussion of the most important challenge for pharma today
- Hear the views of expert speakers from a physician, payer, patient and pharma perspective, all actively involved in addressing this challenge
- Reflect on your own company strategy through informed discussion with the faculty and like-minded senior influencers from leading pharma companies
Expert Faculty
Paul Rowe
Vice President, Head of Global Medical, Immunology, Sanofi
Jason Spangler
Chief Executive Officer
Innovation and Value Initiative
Clinical Psychologist Chief Executive Officer
Novartis
Chief Medical Officer
Angelini Pharma
Chief Medical Officer
Norgine
Head of Government Affairs
& Global Public Health
ViiV Healthcare
Senior Director, Endpoints and Measurement Strategy, Janssen/J&J
Cassandra Trimnell
Founder & Executive Director, Patient Advocacy Consultant
Chief Executive Officer
Myeloma UK
Founder & Patient Advocate
Strive for Five and Beyond
Behavioural Scientist & Founder
Active Research
Chief Executive Officer
Phytome Life Sciences
Expert Faculty
Jason Spangler
Chief Executive Officer
Innovation and Value Initiative
Paul Rowe
Vice President, Head of Global Medical, Immunology, Sanofi
Elizabeth (Nicki) Bush
Senior Director, Endpoints and Measurement Strategy, Janssen/J&J
Cassandra Trimnell
Founder & Executive Director, Patient Advocacy Consultant
Sophie Castell
Chief Executive Officer, Myeloma UK
Steve Clark
Founder & Patient Advocate, Strive for Five and Beyond
Chris Harvey
Behavioural Scientist & Founder, Active Research
Sebastian Vaughan
Chief Executive Officer, Phytome Life Sciences
Pablo Barriga
Clinical Psychologist Chief Executive Officer, Novartis
Agnese Cattaneo
Chief Medical Officer, Angelini Pharma
David Gillen
Chief Medical Officer, Norgine
Helen McDowell
Head of Government Affairs
& Global Public Health, ViiV Healthcare
What is the Renaissance Series?
Expert exchange on disruptive drivers in healthcare
Adelphi’s Renaissance events have, over the years, become established as unique, one day invitation-only forums, at which senior Pharma leaders have the opportunity for discussion of the most dynamic drivers of major and disruptive change in Pharma in an intimate setting.
One Day Thought Leadership Forums based on issues that are driving major change in our industry, most recent forums have addressed:
- Transforming Value Transforming Trust 2022
- Striving for Transformational Value 2018-2020
- Patientcentricity: Defining our role 2016-2017
- Real World Evidence: the new standard of proof? 2014-2015
- Personalised Medicine: Moving from promise to practice 2012-2013
Each Adelphi Renaissance forum has its own unique expert faculty, who are passionate about the topic, representing a range of perspectives from academia, the medical profession, pharma industry, patients, regulatory and payer bodies.
What is the Renaissance Series?
Adelphi’s Renaissance events have, over the years, become established as unique, one day invitation-only forums, at which senior Pharma leaders have the opportunity for discussion of the most dynamic drivers of major and disruptive change in Pharma in an intimate setting.
One Day Thought Leadership Forums based on issues that are driving major change in our industry, most recent forums have addressed:
- Transforming Value Transforming Trust 2022
- Striving for Transformational Value 2018-2020
- Patientcentricity: Defining our role 2016-2017
- Real World Evidence: the new standard of proof? 2014-2015
- Personalised Medicine: Moving from promise to practice 2012-2013
Each Adelphi Renaissance forum has its own unique expert faculty, who are passionate about the topic, representing a range of perspectives from academia, the medical profession, pharma industry, patients, regulatory and payer bodies.
